Skip to main content
Erschienen in: Der Schmerz 5/2008

01.10.2008 | Übersichten

Therapie primärer chronischer Kopfschmerzen

Chronische Migräne, chronischer Kopfschmerz vom Spannungstyp und andere chronische tägliche Kopfschmerzen

verfasst von: Prof. Dr. A. Straube, A. May, P. Kropp, Z. Katsarava, G. Haag, C. Lampl, P.S. Sándor, H.-C. Diener, S. Evers

Erschienen in: Der Schmerz | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Kriterien der International Headache Society (IHS) definieren 4 primäre Kopfschmerzerkrankungen, die zu täglichen Dauerkopfschmerzen führen können:
  • chronische Migräne,
  • Kopfschmerz vom Spannungstyp,
  • Hemicrania continua,
  • neu aufgetretener täglicher Kopfschmerz.
In der Praxis ist davon häufig der Kopfschmerz durch Medikamentenübergebrauch (früher Analgetikakopfschmerz) abzugrenzen. Die jetzt von der Deutschen, Österreichischen und Schweizer Kopfschmerzgesellschaft gemeinsam vorgelegte Therapieleitlinie fasst die Literatur zur Therapie dieser Kopfschmerzformen zusammen und gibt Therapieempfehlungen, die die Literaturevidenz, aber auch die Praktikabilität berücksichtigen.
Literatur
1.
Zurück zum Zitat Pfaffenrath V, Brune K, Diener HC et al. (1998) Die Behandlung des Kopfschmerzes vom Spannungstyp. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 17: 91–100 Pfaffenrath V, Brune K, Diener HC et al. (1998) Die Behandlung des Kopfschmerzes vom Spannungstyp. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 17: 91–100
2.
Zurück zum Zitat Diener HC (2005) Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl. Thieme, Stuttgart Diener HC (2005) Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl. Thieme, Stuttgart
3.
Zurück zum Zitat Olesen J, Bousser M-G, Diener H et al. (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24 [suppl 1]: 1–160 Olesen J, Bousser M-G, Diener H et al. (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24 [suppl 1]: 1–160
4.
Zurück zum Zitat Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 8: 475–483 Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 8: 475–483
5.
Zurück zum Zitat May A, Straube A, Peikert A, Diener H (2005) Diagnostik und apparative Zusatzuntersuchungen bei Kopfschmerzen. In: Diener H (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart, S 476–479 May A, Straube A, Peikert A, Diener H (2005) Diagnostik und apparative Zusatzuntersuchungen bei Kopfschmerzen. In: Diener H (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart, S 476–479
6.
Zurück zum Zitat Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches. Field trial of revised IHS criteria. Neurology 47: 871–875PubMed Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches. Field trial of revised IHS criteria. Neurology 47: 871–875PubMed
7.
Zurück zum Zitat Silberstein SD, Lipton RB (2000) Chronic daily headache. Curr Opin Neurol 13: 277–283PubMed Silberstein SD, Lipton RB (2000) Chronic daily headache. Curr Opin Neurol 13: 277–283PubMed
8.
Zurück zum Zitat Mitsikostas DD, Tsaklakidou D, Athanasiadis N, Thomas A (1996) The prevalence of headache in Greece: correlations to latitude and climatological factors. Headache 36: 168–173PubMed Mitsikostas DD, Tsaklakidou D, Athanasiadis N, Thomas A (1996) The prevalence of headache in Greece: correlations to latitude and climatological factors. Headache 36: 168–173PubMed
9.
Zurück zum Zitat Pascual J, Colas R, Castillo J (2001) Epidemiology of chronic daily headache. Curr Pain Headache Rep 5: 529–536PubMed Pascual J, Colas R, Castillo J (2001) Epidemiology of chronic daily headache. Curr Pain Headache Rep 5: 529–536PubMed
10.
Zurück zum Zitat Colas R, Munoz P, Temprano R et al. (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62: 1338–1342PubMed Colas R, Munoz P, Temprano R et al. (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62: 1338–1342PubMed
11.
Zurück zum Zitat Láinez MJA, Monzón MJ (2001) Chronic daily headache. Curr Neurol Neurosci Rep 1: 118–124PubMed Láinez MJA, Monzón MJ (2001) Chronic daily headache. Curr Neurol Neurosci Rep 1: 118–124PubMed
12.
Zurück zum Zitat Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106: 81–89PubMed Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106: 81–89PubMed
13.
Zurück zum Zitat Zwart JA, Dyb G, Hagen K et al. (2003) Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 61: 160–164PubMed Zwart JA, Dyb G, Hagen K et al. (2003) Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 61: 160–164PubMed
14.
Zurück zum Zitat Zwart JA, Dyb G, Hagen K et al. (2004) Analgesic overuse among subjects with headache, neck, and low back pain. Neurology 62: 1540–1544PubMed Zwart JA, Dyb G, Hagen K et al. (2004) Analgesic overuse among subjects with headache, neck, and low back pain. Neurology 62: 1540–1544PubMed
15.
Zurück zum Zitat Katsarava Z, Schneeweiss S, Kurth T et al. (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62: 788–790PubMed Katsarava Z, Schneeweiss S, Kurth T et al. (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62: 788–790PubMed
16.
Zurück zum Zitat Wang SJ, Fuh JL, Lu SR, Juang KD (2006) Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 66: 193–197PubMed Wang SJ, Fuh JL, Lu SR, Juang KD (2006) Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 66: 193–197PubMed
17.
Zurück zum Zitat Dyb G, Holmen TL, Zwart JA (2006) Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 66: 198–220PubMed Dyb G, Holmen TL, Zwart JA (2006) Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 66: 198–220PubMed
18.
Zurück zum Zitat Juang K-D, Wang S-J, Fuh J-L et al. (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 40: 818–823PubMed Juang K-D, Wang S-J, Fuh J-L et al. (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 40: 818–823PubMed
19.
Zurück zum Zitat Radat F, Swendsen J (2005) Psychiatric comorbidity in migraine: a review. Cephalalgia 25: 165–178PubMed Radat F, Swendsen J (2005) Psychiatric comorbidity in migraine: a review. Cephalalgia 25: 165–178PubMed
20.
Zurück zum Zitat Olesen J, Bousser MG, Diener HC et al. for the Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26: 742–746PubMed Olesen J, Bousser MG, Diener HC et al. for the Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26: 742–746PubMed
21.
Zurück zum Zitat De Tommaso M, Losito L, Difruscolo O et al. (2005) Changes in cortical processing of pain in chronic migraine. Headache 45: 1208–1218 De Tommaso M, Losito L, Difruscolo O et al. (2005) Changes in cortical processing of pain in chronic migraine. Headache 45: 1208–1218
22.
Zurück zum Zitat Aurora SK, Barrodale P, Chronicle EP, Mulleners WM (2005) Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache 45: 546–552PubMed Aurora SK, Barrodale P, Chronicle EP, Mulleners WM (2005) Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache 45: 546–552PubMed
23.
Zurück zum Zitat Diener HC, Limmroth V, Fritsche G et al. (2005) Therapie der Migräneattacke und Migräneprophylaxe. In: In: Diener H (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl. Thieme, Stuttgart Diener HC, Limmroth V, Fritsche G et al. (2005) Therapie der Migräneattacke und Migräneprophylaxe. In: In: Diener H (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl. Thieme, Stuttgart
24.
Zurück zum Zitat Dowson AJ, Dodick DW, Limmroth V (2005) Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 19: 483–497PubMed Dowson AJ, Dodick DW, Limmroth V (2005) Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 19: 483–497PubMed
25.
Zurück zum Zitat Silvestrini M, Bartolini M, Coccia M et al. (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23: 820–824PubMed Silvestrini M, Bartolini M, Coccia M et al. (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23: 820–824PubMed
26.
Zurück zum Zitat Rothrock JF, Parada VA, Drinkard R et al. (2005) Predictors of a negative response to topiramate therapy in patients with chronic migraine. Headache 45: 932–935PubMed Rothrock JF, Parada VA, Drinkard R et al. (2005) Predictors of a negative response to topiramate therapy in patients with chronic migraine. Headache 45: 932–935PubMed
27.
Zurück zum Zitat Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42: 796–803PubMed Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42: 796–803PubMed
28.
Zurück zum Zitat Bartolini M, Silvestrini M, Taffi R et al. (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 28: 277–279PubMed Bartolini M, Silvestrini M, Taffi R et al. (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 28: 277–279PubMed
29.
Zurück zum Zitat Diener H, Bussone G, Van Oene J et al. TOPMAT-MIG-201 (TOP-CHROME) Study Group (2006) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27: 814–823 Diener H, Bussone G, Van Oene J et al. TOPMAT-MIG-201 (TOP-CHROME) Study Group (2006) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27: 814–823
30.
Zurück zum Zitat Rothrock J (1999) Management of chronic daily headache utilizing a uniform treatment pathway. Headache 39: 650–653PubMed Rothrock J (1999) Management of chronic daily headache utilizing a uniform treatment pathway. Headache 39: 650–653PubMed
31.
Zurück zum Zitat Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 41: 271–278PubMed Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 41: 271–278PubMed
32.
Zurück zum Zitat Tomkins GE, Jackson JL, O’Malley PG et al. (2001) Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 111: 54–63PubMed Tomkins GE, Jackson JL, O’Malley PG et al. (2001) Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 111: 54–63PubMed
33.
Zurück zum Zitat Matharu MS, Bartsch T, Ward N et al. (2004) Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 127: 220–230PubMed Matharu MS, Bartsch T, Ward N et al. (2004) Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 127: 220–230PubMed
34.
Zurück zum Zitat Mauskop A (2005) Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia 25: 82–86PubMed Mauskop A (2005) Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia 25: 82–86PubMed
35.
Zurück zum Zitat Mathew NT, Frishberg BM, Gawel M et al. BOTOX CDH Study Group (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45: 293–307PubMed Mathew NT, Frishberg BM, Gawel M et al. BOTOX CDH Study Group (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45: 293–307PubMed
36.
Zurück zum Zitat Dodick DW, Mauskop A, Elkind AH et al. BOTOX CDH Study Group (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45: 315–324PubMed Dodick DW, Mauskop A, Elkind AH et al. BOTOX CDH Study Group (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45: 315–324PubMed
37.
Zurück zum Zitat Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C et al. (2005) Preventive non-pharmacological treatment and nitric oxide in chronic migraine. J Headache Pain 6: 341–342PubMed Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C et al. (2005) Preventive non-pharmacological treatment and nitric oxide in chronic migraine. J Headache Pain 6: 341–342PubMed
38.
Zurück zum Zitat Penzien DB, Rains JC, Lipchik GL et al. (2005) Future directions in behavioural headache research: applications for an evolving health care environment. Headache 45: 526–534PubMed Penzien DB, Rains JC, Lipchik GL et al. (2005) Future directions in behavioural headache research: applications for an evolving health care environment. Headache 45: 526–534PubMed
39.
Zurück zum Zitat Karli N, Zarifoglu M, Calisir N, Akgoz S (2005) Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia 25: 444–451PubMed Karli N, Zarifoglu M, Calisir N, Akgoz S (2005) Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia 25: 444–451PubMed
40.
Zurück zum Zitat Ulrich V, Gervil M, Olesen J (2004) The relative influence of environment and genes in episodic tension-type headache. Neurology 62: 2065–2068PubMed Ulrich V, Gervil M, Olesen J (2004) The relative influence of environment and genes in episodic tension-type headache. Neurology 62: 2065–2068PubMed
41.
Zurück zum Zitat Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19: 602–621PubMed Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19: 602–621PubMed
42.
Zurück zum Zitat Christensen MB, Bendtsen L, Ashina M, Jensen R (2005) Experimental induction of muscle tenderness and headache in tension-type headache patients. Cephalalgia 25: 1061–1067PubMed Christensen MB, Bendtsen L, Ashina M, Jensen R (2005) Experimental induction of muscle tenderness and headache in tension-type headache patients. Cephalalgia 25: 1061–1067PubMed
43.
Zurück zum Zitat Ashina S, Bendtsen L, Ashina M (2005) Pathophysiology of tension-type headache. Curr Pain Headache Rep 9: 415–422PubMed Ashina S, Bendtsen L, Ashina M (2005) Pathophysiology of tension-type headache. Curr Pain Headache Rep 9: 415–422PubMed
44.
Zurück zum Zitat Holzhammer J, Wöber C (2006) Alimentäre Triggerfaktoren bei Migräne und Kopfschmerz vom Spannungstyp. Schmerz 20: 151–159PubMed Holzhammer J, Wöber C (2006) Alimentäre Triggerfaktoren bei Migräne und Kopfschmerz vom Spannungstyp. Schmerz 20: 151–159PubMed
45.
Zurück zum Zitat Martínez-Martín P, Raffaelli E, Titus F et al. (2001) Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 21: 604–610PubMed Martínez-Martín P, Raffaelli E, Titus F et al. (2001) Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 21: 604–610PubMed
46.
Zurück zum Zitat Haag G, Evers S, May A et al. (2004) Selbstmedikation bei Migräne und Kopfscherzen vom Spannungstyp. Evidenzbasierte Empfehlungen der Deutschen Migräne- und Kopfschmerz-Gesellschaft (DMKG). Nervenheilkunde 23: 415–430 Haag G, Evers S, May A et al. (2004) Selbstmedikation bei Migräne und Kopfscherzen vom Spannungstyp. Evidenzbasierte Empfehlungen der Deutschen Migräne- und Kopfschmerz-Gesellschaft (DMKG). Nervenheilkunde 23: 415–430
47.
Zurück zum Zitat Cerbo R, Barbanti P, Fabbrini G et al. (1998) Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications. Headache 38: 453–457PubMed Cerbo R, Barbanti P, Fabbrini G et al. (1998) Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications. Headache 38: 453–457PubMed
48.
Zurück zum Zitat White AR, Resch KL, Chan JC et al. (2000) Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial. Cephalalgia 20: 632–637PubMed White AR, Resch KL, Chan JC et al. (2000) Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial. Cephalalgia 20: 632–637PubMed
49.
Zurück zum Zitat Bronfort G, Nilsson N, Haas M et al. (2004) Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev 3: CD001878PubMed Bronfort G, Nilsson N, Haas M et al. (2004) Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev 3: CD001878PubMed
50.
Zurück zum Zitat Verhagen AP, Damen L, Berger MY et al. (2005) Conservative treatments of children with episodic tension-type headache. A systematic review. J Neurol 252: 1147–1154PubMed Verhagen AP, Damen L, Berger MY et al. (2005) Conservative treatments of children with episodic tension-type headache. A systematic review. J Neurol 252: 1147–1154PubMed
51.
Zurück zum Zitat Russell MB, Ostergaard S, Bendtsen L, Olesen J (1999) Familial occurrence of chronic tension-type headache. Cephalalgia 19: 207–210PubMed Russell MB, Ostergaard S, Bendtsen L, Olesen J (1999) Familial occurrence of chronic tension-type headache. Cephalalgia 19: 207–210PubMed
52.
Zurück zum Zitat Spierings ELH, Ranke AH, Schroevers M, Honkoop PC (2000) Chronic daily headache: a time perspective. Headache 40: 306–310PubMed Spierings ELH, Ranke AH, Schroevers M, Honkoop PC (2000) Chronic daily headache: a time perspective. Headache 40: 306–310PubMed
53.
Zurück zum Zitat Breslau N, Schultz LR, Stewart WF et al. (2000) Headache and major depression. Is the association specific to migraine? Neurology 54: 308–313PubMed Breslau N, Schultz LR, Stewart WF et al. (2000) Headache and major depression. Is the association specific to migraine? Neurology 54: 308–313PubMed
54.
Zurück zum Zitat Bendtsen L (2000) Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 20: 486–508PubMed Bendtsen L (2000) Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 20: 486–508PubMed
55.
Zurück zum Zitat Ashina M, Lassen LH, Bendtsen L et al. (1999) Effect of inhibition of nitiric oxide synthase on chronic tension-type headache: a randomized crossover trial. Lancet 353: 287–289PubMed Ashina M, Lassen LH, Bendtsen L et al. (1999) Effect of inhibition of nitiric oxide synthase on chronic tension-type headache: a randomized crossover trial. Lancet 353: 287–289PubMed
56.
Zurück zum Zitat Jensen R, Olesen J (2000) Tension-type headache: an update on mechanisms and treatment. Curr Opin Neurol 13: 285–289PubMed Jensen R, Olesen J (2000) Tension-type headache: an update on mechanisms and treatment. Curr Opin Neurol 13: 285–289PubMed
57.
Zurück zum Zitat Ashina M (2004) Neurobiology of chronic tension-type headache. Cephalalgia 24: 161–172PubMed Ashina M (2004) Neurobiology of chronic tension-type headache. Cephalalgia 24: 161–172PubMed
58.
Zurück zum Zitat Fernandez-de-Las-Penas C, Alonso-Blanco C, Cuadrado ML et al. (2006) Myofascial trigger points and their relationship to headache clinical parameters in chronic tension-type headache. Headache 46: 1264–1272PubMed Fernandez-de-Las-Penas C, Alonso-Blanco C, Cuadrado ML et al. (2006) Myofascial trigger points and their relationship to headache clinical parameters in chronic tension-type headache. Headache 46: 1264–1272PubMed
59.
Zurück zum Zitat Makowska A, Panfil C, Ellrich J (2005) Nerve growth factor injection into semispinal neck muscle evokes sustained facilitation of the jaw-opening reflex in anesthetized mice – possible implications for tension-type headache. Exp Neurol 191: 301–309PubMed Makowska A, Panfil C, Ellrich J (2005) Nerve growth factor injection into semispinal neck muscle evokes sustained facilitation of the jaw-opening reflex in anesthetized mice – possible implications for tension-type headache. Exp Neurol 191: 301–309PubMed
60.
Zurück zum Zitat Makowska A, Panfil C, Ellrich J (2005) Long-term potentiation of orofacial sensorimotor processing by noxious input from the semispinal neck muscle in mice. Cephalalgia 25: 109–116PubMed Makowska A, Panfil C, Ellrich J (2005) Long-term potentiation of orofacial sensorimotor processing by noxious input from the semispinal neck muscle in mice. Cephalalgia 25: 109–116PubMed
61.
Zurück zum Zitat Panfil C, Makowska A, Ellrich J (2006) Brainstem and cervical spinal cord fos immunoreactivity evoked by nerve growth factor injection into neck muscles in mice. Cephalalgia 26: 128–135PubMed Panfil C, Makowska A, Ellrich J (2006) Brainstem and cervical spinal cord fos immunoreactivity evoked by nerve growth factor injection into neck muscles in mice. Cephalalgia 26: 128–135PubMed
62.
Zurück zum Zitat Schmidt-Wilcke T, Leinisch E, Straube A et al. (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65: 1483–1486PubMed Schmidt-Wilcke T, Leinisch E, Straube A et al. (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65: 1483–1486PubMed
63.
Zurück zum Zitat Hannerz J, Jogestrand T (1998) Is chronic tension-type headache a vascular headache? The relation between chronic tension-type headache and cranial hemodynamics. Headache 38: 668–675PubMed Hannerz J, Jogestrand T (1998) Is chronic tension-type headache a vascular headache? The relation between chronic tension-type headache and cranial hemodynamics. Headache 38: 668–675PubMed
64.
Zurück zum Zitat Hannerz J, Schnell PO, Larsson S, Jacobsson H (2004) Blood pool scintigraphy of the skull in relation to head-down tilt provocation in patients with chronic tension-type headache and controls. Headache 44: 223–229PubMed Hannerz J, Schnell PO, Larsson S, Jacobsson H (2004) Blood pool scintigraphy of the skull in relation to head-down tilt provocation in patients with chronic tension-type headache and controls. Headache 44: 223–229PubMed
65.
Zurück zum Zitat Silberstein SD, Olesen J, Bousser MG et al. International Headache Society (2005) The international classification of headache disorders, 2nd edn. (ICHD-II-)revision of criteria for 8.2 medication-overuse headache. Cephalalgia 25: 460–465PubMed Silberstein SD, Olesen J, Bousser MG et al. International Headache Society (2005) The international classification of headache disorders, 2nd edn. (ICHD-II-)revision of criteria for 8.2 medication-overuse headache. Cephalalgia 25: 460–465PubMed
66.
Zurück zum Zitat Holroyd KA, O’Donnell FJ, Stensland M et al. (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination. JAMA 285: 2208–2215PubMed Holroyd KA, O’Donnell FJ, Stensland M et al. (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination. JAMA 285: 2208–2215PubMed
67.
Zurück zum Zitat Redillas C, Solomon S (2000) Prophylactic pharmacological treatment of chronic daily headache. Headache 40: 83–102PubMed Redillas C, Solomon S (2000) Prophylactic pharmacological treatment of chronic daily headache. Headache 40: 83–102PubMed
68.
Zurück zum Zitat Ashina S, Bendtsen L, Jensen R (2004) Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain 108: 108–114PubMed Ashina S, Bendtsen L, Jensen R (2004) Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain 108: 108–114PubMed
69.
Zurück zum Zitat Pfaffenrath V, Diener HC, Isler H et al. (1994) Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 14: 149–155PubMed Pfaffenrath V, Diener HC, Isler H et al. (1994) Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 14: 149–155PubMed
70.
Zurück zum Zitat Holroyd KA, Labus JS, O’Donnell FJ, Cordingley GE (2003)Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation. Headache 43: 999–1004PubMed Holroyd KA, Labus JS, O’Donnell FJ, Cordingley GE (2003)Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation. Headache 43: 999–1004PubMed
71.
Zurück zum Zitat Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 3: CD002919PubMed Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 3: CD002919PubMed
72.
Zurück zum Zitat Fogelholm R, Murros K (1992) Tizanidine in chronic tension-type headache: a placebo controlled, double-blind cross over study. Headache 32: 509–513PubMed Fogelholm R, Murros K (1992) Tizanidine in chronic tension-type headache: a placebo controlled, double-blind cross over study. Headache 32: 509–513PubMed
73.
Zurück zum Zitat Murros K, Kataja M, Hedman C et al. (2000) Modified-release formulation of tizanidine in chronic tension-type headache. Headache 40: 633–637PubMed Murros K, Kataja M, Hedman C et al. (2000) Modified-release formulation of tizanidine in chronic tension-type headache. Headache 40: 633–637PubMed
74.
Zurück zum Zitat Vernon H, McDermaid CS, Hagino C (1999) Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache. Complement Ther Med 7: 142–155PubMed Vernon H, McDermaid CS, Hagino C (1999) Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache. Complement Ther Med 7: 142–155PubMed
75.
Zurück zum Zitat Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62: 1706–1711PubMed Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62: 1706–1711PubMed
76.
Zurück zum Zitat Langemark M, Olesen J (1994) Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 34: 20–24PubMed Langemark M, Olesen J (1994) Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 34: 20–24PubMed
77.
Zurück zum Zitat Spira PJ, Beran RG, Australian Gabapentin Chronic Daily Headache Group (2003) Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 61: 1753–1759PubMed Spira PJ, Beran RG, Australian Gabapentin Chronic Daily Headache Group (2003) Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 61: 1753–1759PubMed
78.
Zurück zum Zitat Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26: 1203–1208PubMed Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26: 1203–1208PubMed
79.
Zurück zum Zitat Robbins L (1999) Long-acting opioids for severe chronic daily headache. Headache Q 10: 135–139 Robbins L (1999) Long-acting opioids for severe chronic daily headache. Headache Q 10: 135–139
80.
Zurück zum Zitat Saper JR, Lake AE 3rd, Hamel RL et al. (2004) Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology 62: 1687–1694PubMed Saper JR, Lake AE 3rd, Hamel RL et al. (2004) Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology 62: 1687–1694PubMed
81.
Zurück zum Zitat Bettucci D, Testa L, Calzoni S et al. (2006) Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life. J Headache Pain 7: 34–36PubMed Bettucci D, Testa L, Calzoni S et al. (2006) Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life. J Headache Pain 7: 34–36PubMed
82.
Zurück zum Zitat Rampello L, Alvano A, Chiechio S et al. (2004) Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology 50: 322–328PubMed Rampello L, Alvano A, Chiechio S et al. (2004) Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology 50: 322–328PubMed
83.
Zurück zum Zitat Bernstein DA, Borkovec TD (1975) Entspannungstraining. Handbuch der Progressiven Muskelrelaxation. Pfeiffer, München Bernstein DA, Borkovec TD (1975) Entspannungstraining. Handbuch der Progressiven Muskelrelaxation. Pfeiffer, München
84.
Zurück zum Zitat Larsson B, Andrasik F (2002) Relaxation treatment of recurrent headaches in children and adolescents. In: Guidetti V, Russell G, Sillanpää M, Winner P (eds) Headaches and migraine in childhood and adolescence. Dunitz, London, UK, pp 307–316 Larsson B, Andrasik F (2002) Relaxation treatment of recurrent headaches in children and adolescents. In: Guidetti V, Russell G, Sillanpää M, Winner P (eds) Headaches and migraine in childhood and adolescence. Dunitz, London, UK, pp 307–316
85.
Zurück zum Zitat Andrasik F, Walch SE (2003) Headaches. In: Nezu AM, Nezu CM, Geller PA (eds) Handbook of psychology, vol 9. Wiley, New York, pp 245–266 Andrasik F, Walch SE (2003) Headaches. In: Nezu AM, Nezu CM, Geller PA (eds) Handbook of psychology, vol 9. Wiley, New York, pp 245–266
86.
Zurück zum Zitat Harpole LH, Samsa GP, Jurgelski AE et al. (2003) Headache management program improves outcome for chronic headache. Headache 43: 715–723PubMed Harpole LH, Samsa GP, Jurgelski AE et al. (2003) Headache management program improves outcome for chronic headache. Headache 43: 715–723PubMed
87.
Zurück zum Zitat Andrasik F, Lords AO, Biofeedback (2004) Mosbys complementary & alternative medicine: a research-based approach, 2nd edn. Mosby, St. Louis Andrasik F, Lords AO, Biofeedback (2004) Mosbys complementary & alternative medicine: a research-based approach, 2nd edn. Mosby, St. Louis
88.
Zurück zum Zitat Sarafino EP, Goehring P (2000) Age comparisons in acquiring biofeedback control and success in reducing headache pain. Ann Behav Med 22: 10–16PubMed Sarafino EP, Goehring P (2000) Age comparisons in acquiring biofeedback control and success in reducing headache pain. Ann Behav Med 22: 10–16PubMed
89.
Zurück zum Zitat Penzien DB, Rains JC, Andrasik F (2002) Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback 27: 163–181PubMed Penzien DB, Rains JC, Andrasik F (2002) Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback 27: 163–181PubMed
90.
Zurück zum Zitat Torelli P, Jensen R, Olesen J (2004) Physiotherapy for tension-type headache: a controlled study. Cephalalgia 24: 29–36PubMed Torelli P, Jensen R, Olesen J (2004) Physiotherapy for tension-type headache: a controlled study. Cephalalgia 24: 29–36PubMed
91.
Zurück zum Zitat Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW (2002) Treatment of headache with botulinum toxin A – a review according to evidence-based medicine criteria. Cephalalgia 22: 699–710PubMed Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW (2002) Treatment of headache with botulinum toxin A – a review according to evidence-based medicine criteria. Cephalalgia 22: 699–710PubMed
92.
Zurück zum Zitat Schulte-Mattler WJ, Krack P, BoNTTH Study Group (2004) Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain 109: 110–114PubMed Schulte-Mattler WJ, Krack P, BoNTTH Study Group (2004) Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain 109: 110–114PubMed
93.
Zurück zum Zitat Vickers AJ, Rees RW, Zollman CE et al. (2004) Acupuncture for chronic headache in primary care: large, pragmatic, randomized trial. BMJ 328: 744PubMed Vickers AJ, Rees RW, Zollman CE et al. (2004) Acupuncture for chronic headache in primary care: large, pragmatic, randomized trial. BMJ 328: 744PubMed
94.
Zurück zum Zitat Melchart D, Streng A, Hoppe A et al. (2005) Acupuncture in patients with tension-type headache: randomized controlled trial. BMJ 331: 376–382PubMed Melchart D, Streng A, Hoppe A et al. (2005) Acupuncture in patients with tension-type headache: randomized controlled trial. BMJ 331: 376–382PubMed
95.
Zurück zum Zitat Coeytaux RR, Kaufman JS, Kaptchuk TJ et al. (2005) A randomized, controlled trial of acupuncture for chronic daily headache. Headache 45: 1113–1123PubMed Coeytaux RR, Kaufman JS, Kaptchuk TJ et al. (2005) A randomized, controlled trial of acupuncture for chronic daily headache. Headache 45: 1113–1123PubMed
96.
Zurück zum Zitat Evers S, Pothmann R, Überall M et al. (2001) Therapie idiopathischer Kopfschmerzen im Kindesalter. Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 20: 306–315 Evers S, Pothmann R, Überall M et al. (2001) Therapie idiopathischer Kopfschmerzen im Kindesalter. Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 20: 306–315
97.
Zurück zum Zitat Peres MF, Silberstein SD, Nahmias S et al. (2000) Hemicrania continua is not that rare. Neurology 57: 948–951 Peres MF, Silberstein SD, Nahmias S et al. (2000) Hemicrania continua is not that rare. Neurology 57: 948–951
98.
Zurück zum Zitat Newman LC, Spears RC, Lay CL (2004) Hemicrania continua: a third case in which attacks alternate sides. Headache 44: 821–823PubMed Newman LC, Spears RC, Lay CL (2004) Hemicrania continua: a third case in which attacks alternate sides. Headache 44: 821–823PubMed
99.
Zurück zum Zitat Matharu MS, Bradbury P, Swash M (2006) Hemicrania continua: side alternation and response to topiramate. Cephalalgia 26: 341–344PubMed Matharu MS, Bradbury P, Swash M (2006) Hemicrania continua: side alternation and response to topiramate. Cephalalgia 26: 341–344PubMed
100.
Zurück zum Zitat Sjaastad O, Stovner LJ, Stolt Nielsen A et al. (1995) CPH and hemicrania continua: requirements of high indomethacin dosages – an ominous sign? Headache 35: 363–367PubMed Sjaastad O, Stovner LJ, Stolt Nielsen A et al. (1995) CPH and hemicrania continua: requirements of high indomethacin dosages – an ominous sign? Headache 35: 363–367PubMed
101.
Zurück zum Zitat Pareja JA, Vincent M, Antonaci F, Sjaastad O (2001) Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia 21: 874–877PubMed Pareja JA, Vincent M, Antonaci F, Sjaastad O (2001) Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia 21: 874–877PubMed
102.
Zurück zum Zitat Hannerz J (2000) Chronic bilateral headache responding to indomethazin. Headache 40: 840–843PubMed Hannerz J (2000) Chronic bilateral headache responding to indomethazin. Headache 40: 840–843PubMed
103.
Zurück zum Zitat Lay CL, Newman LC (1999) Posttraumatic hemicrania continua. Headache 39: 275–279PubMed Lay CL, Newman LC (1999) Posttraumatic hemicrania continua. Headache 39: 275–279PubMed
104.
Zurück zum Zitat Levy MJ, Matharu MS, Meeran K et al. (2005) The clinical characteristics of headache in patients with pituitary tumours. Brain 128: 1921–1930PubMed Levy MJ, Matharu MS, Meeran K et al. (2005) The clinical characteristics of headache in patients with pituitary tumours. Brain 128: 1921–1930PubMed
105.
Zurück zum Zitat Vikelis M, Xifaras M, Magoufis G et al. (2005) Headache attributed to unruptured saccular aneurysm, mimicking hemicrania continua. J Headache Pain 6: 156–158PubMed Vikelis M, Xifaras M, Magoufis G et al. (2005) Headache attributed to unruptured saccular aneurysm, mimicking hemicrania continua. J Headache Pain 6: 156–158PubMed
106.
Zurück zum Zitat Rogalewski A, Evers S (2005) Symptomatic hemicrania continua after internal carotid artery dissection. Headache 45: 167–169PubMed Rogalewski A, Evers S (2005) Symptomatic hemicrania continua after internal carotid artery dissection. Headache 45: 167–169PubMed
107.
Zurück zum Zitat Matharu MS, Cohen AS, McGonigle DJ et al. (2004) Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 44: 747–746PubMed Matharu MS, Cohen AS, McGonigle DJ et al. (2004) Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 44: 747–746PubMed
108.
Zurück zum Zitat Spears RC (2006) Hemicrania continua: a case in which a patient experienced complete relief on melatonin. Headache 46: 524–527PubMed Spears RC (2006) Hemicrania continua: a case in which a patient experienced complete relief on melatonin. Headache 46: 524–527PubMed
109.
Zurück zum Zitat Rajabally YA, Jacob S (2005) Hemicrania continua responsive to verapamil. Headache 45: 1082–1083PubMed Rajabally YA, Jacob S (2005) Hemicrania continua responsive to verapamil. Headache 45: 1082–1083PubMed
110.
Zurück zum Zitat Lanteri-Minet M, Auray JP, El Hasnaoui A et al. (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102: 143–149PubMed Lanteri-Minet M, Auray JP, El Hasnaoui A et al. (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102: 143–149PubMed
111.
Zurück zum Zitat Chakravarty A (2003) Chronic daily headaches: clinical profile in Indian patients. Cephalalgia 23: 348–353PubMed Chakravarty A (2003) Chronic daily headaches: clinical profile in Indian patients. Cephalalgia 23: 348–353PubMed
112.
Zurück zum Zitat Li D, Rozen TD (2002) The clinical characterization of new daily persistent headache. Cephalalgia 22: 66–69PubMed Li D, Rozen TD (2002) The clinical characterization of new daily persistent headache. Cephalalgia 22: 66–69PubMed
113.
Zurück zum Zitat Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near daily headaches: proposed revisions to the IHS-criteria. Headache 34: 1–7 Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near daily headaches: proposed revisions to the IHS-criteria. Headache 34: 1–7
114.
Zurück zum Zitat Vanast WJ, Diaz-Mitoma F, Tyrrell DL (1987) Hypothesis: chronic benign daily headache is an immune disorder with a viral trigger. Headache 27: 138–142PubMed Vanast WJ, Diaz-Mitoma F, Tyrrell DL (1987) Hypothesis: chronic benign daily headache is an immune disorder with a viral trigger. Headache 27: 138–142PubMed
115.
Zurück zum Zitat Diaz-Mitoma F, Vanast WJ, Tyrrell DL (1987) Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1: 411–415PubMed Diaz-Mitoma F, Vanast WJ, Tyrrell DL (1987) Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1: 411–415PubMed
116.
Zurück zum Zitat Hamada T, Ohshima K, Ide Y et al. (1991) A case of new daily persistent headache with elevated antibodies to Epstein-Barr virus. Jpn J Med 30: 161–163PubMed Hamada T, Ohshima K, Ide Y et al. (1991) A case of new daily persistent headache with elevated antibodies to Epstein-Barr virus. Jpn J Med 30: 161–163PubMed
117.
Zurück zum Zitat Mack KJ (2004) What incites new daily persistent headache in children? Pediatr Neurol 31: 122–125PubMed Mack KJ (2004) What incites new daily persistent headache in children? Pediatr Neurol 31: 122–125PubMed
118.
Zurück zum Zitat Goadsby PJ, Boes C (2002) New daily persistent headache. J Neurol Neurosurg Psychiatry 72 [suppl 2]: ii6–ii9 Goadsby PJ, Boes C (2002) New daily persistent headache. J Neurol Neurosurg Psychiatry 72 [suppl 2]: ii6–ii9
119.
Zurück zum Zitat Rozen TD (2003) New daily persistent headache. Curr Pain Headache Rep 7: 218–223PubMed Rozen TD (2003) New daily persistent headache. Curr Pain Headache Rep 7: 218–223PubMed
120.
Zurück zum Zitat Evans RW, Rozen TD (2001) Etiology and treatment of new daily persistent headache. Headache 41: 830–832PubMed Evans RW, Rozen TD (2001) Etiology and treatment of new daily persistent headache. Headache 41: 830–832PubMed
121.
Zurück zum Zitat Evans RW (2003) New daily persistent headache. Curr Pain Headache Rep 7: 3003–3307 Evans RW (2003) New daily persistent headache. Curr Pain Headache Rep 7: 3003–3307
122.
Zurück zum Zitat Vanast WJ (1986) New daily persistent headaches definition of a benign syndrome. Headache 26: 318 Vanast WJ (1986) New daily persistent headaches definition of a benign syndrome. Headache 26: 318
123.
Zurück zum Zitat Paemeleire K, Bahra A, Evers S et al. (2006) Medication-overuse headache in patients with cluster headache. Neurology 67: 109–113PubMed Paemeleire K, Bahra A, Evers S et al. (2006) Medication-overuse headache in patients with cluster headache. Neurology 67: 109–113PubMed
124.
Zurück zum Zitat Fuh JL, Wang SJ, Lu SR, Juang KD (2005) Does medication overuse headache represent a behavior of dependence? Pain 119: 49–55PubMed Fuh JL, Wang SJ, Lu SR, Juang KD (2005) Does medication overuse headache represent a behavior of dependence? Pain 119: 49–55PubMed
125.
Zurück zum Zitat Radat F, Creach C, Swendsen JD et al. (2005) Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25: 519–522PubMed Radat F, Creach C, Swendsen JD et al. (2005) Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25: 519–522PubMed
126.
Zurück zum Zitat Limmroth V, Katsarava Z, Fritsche G et al. (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011–1014PubMed Limmroth V, Katsarava Z, Fritsche G et al. (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011–1014PubMed
127.
Zurück zum Zitat Fumal A, Laureys S, Di Clemente L et al. (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129: 543–550PubMed Fumal A, Laureys S, Di Clemente L et al. (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129: 543–550PubMed
128.
Zurück zum Zitat Ayzenberg I, Obermann M, Nyhuis P et al. (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26: 1106–1114PubMed Ayzenberg I, Obermann M, Nyhuis P et al. (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26: 1106–1114PubMed
129.
Zurück zum Zitat Relja G, Granato A, Bratina A et al. (2006) Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 26: 589–595PubMed Relja G, Granato A, Bratina A et al. (2006) Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 26: 589–595PubMed
130.
Zurück zum Zitat Katsarava Z, Fritsche G, Muessig M et al. (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57: 1694–1698PubMed Katsarava Z, Fritsche G, Muessig M et al. (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57: 1694–1698PubMed
131.
Zurück zum Zitat Coskun O, Ucler S, Cavdar L, Inan LE (2007) Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications. J Clin Neurosci 14: 334–339PubMed Coskun O, Ucler S, Cavdar L, Inan LE (2007) Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications. J Clin Neurosci 14: 334–339PubMed
132.
Zurück zum Zitat Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache. Neurology 66: 1–5 Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache. Neurology 66: 1–5
133.
Zurück zum Zitat Descombes S, Brefel-Courbon C, Thalamas C et al. (2001) Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache 41: 178–182PubMed Descombes S, Brefel-Courbon C, Thalamas C et al. (2001) Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache 41: 178–182PubMed
134.
Zurück zum Zitat Katsarava Z, Limmroth V, Finke M et al. (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60: 1682–1683PubMed Katsarava Z, Limmroth V, Finke M et al. (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60: 1682–1683PubMed
135.
Zurück zum Zitat Suhr B, Evers S, Bauer B et al. (1999) Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19: 44–49PubMed Suhr B, Evers S, Bauer B et al. (1999) Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19: 44–49PubMed
136.
Zurück zum Zitat Fritsche G, Eberl A, Katsarava Z et al. (2001) Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 45: 229–235PubMed Fritsche G, Eberl A, Katsarava Z et al. (2001) Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 45: 229–235PubMed
137.
Zurück zum Zitat Grazzi L, Andrasik F, D’Amico D et al. (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42: 483–490PubMed Grazzi L, Andrasik F, D’Amico D et al. (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42: 483–490PubMed
138.
Zurück zum Zitat Krymchantowski AV, Moreira PF (2003) Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 23: 982–993PubMed Krymchantowski AV, Moreira PF (2003) Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 23: 982–993PubMed
Metadaten
Titel
Therapie primärer chronischer Kopfschmerzen
Chronische Migräne, chronischer Kopfschmerz vom Spannungstyp und andere chronische tägliche Kopfschmerzen
verfasst von
Prof. Dr. A. Straube
A. May
P. Kropp
Z. Katsarava
G. Haag
C. Lampl
P.S. Sándor
H.-C. Diener
S. Evers
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Der Schmerz / Ausgabe 5/2008
Print ISSN: 0932-433X
Elektronische ISSN: 1432-2129
DOI
https://doi.org/10.1007/s00482-008-0645-9

Weitere Artikel der Ausgabe 5/2008

Der Schmerz 5/2008 Zur Ausgabe

President´s Corner (Mitteilungen der DGSS)

Liebe Kolleginnen und Kollegen

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.